CD8A and hepatocellular carcinoma: CD4+ and CD8+ T cells are predominant in TILs and early clinical studies found that high level of T-cell infiltration in TME results in a lower recurrence rate and a better survival for patients with HCC (Unitt et al. 2006; Cariani et al. 2012).